Literature DB >> 16249391

Expansion of HIV-specific CD4+ and CD8+ T cells by dendritic cells transfected with mRNA encoding cytoplasm- or lysosome-targeted Nef.

Daniel G Kavanagh1, Daniel E Kaufmann, Sherzana Sunderji, Nicole Frahm, Sylvie Le Gall, David Boczkowski, Eric S Rosenberg, David R Stone, Mary N Johnston, Bradford S Wagner, Mohammad T Zaman, Christian Brander, Eli Gilboa, Bruce D Walker, Nina Bhardwaj.   

Abstract

Transfection with synthetic mRNA is a safe and efficient method of delivering antigens to dendritic cells for immunotherapy. Targeting antigens to the lysosome can sometimes enhance the CD4+ T-cell response. We transfected antigen-presenting cells (APCs) with mRNA encoding Gag-p24 and cytoplasmic, lysosomal, and secreted forms of Nef. Antigen-specific cytotoxic T cells were able to lyse the majority of transfected targets, indicating that transfection was efficient. Transfection of APCs with a Nef construct bearing lysosomal targeting signals produced rapid and prolonged antigen presentation to CD4+ and CD8+ T cells. Polyclonal CD4+ and CD8+ T-cell lines recognizing multiple distinct epitopes were expanded by coculture of transfected dendritic cells with peripheral blood mononuclear cells from viremic and aviremic HIV-infected subjects. Importantly, lysosome-targeted antigen drove a significantly greater expansion of Nef-specific CD4+ T cells than cytoplasmic antigen. The frequency of recognition of CD8 but not CD4 epitopes by mRNA-expanded T cells was inversely proportional to sequence entropy and was similar to ex vivo responses from a large chronic cohort. Thus human dendritic cells transfected with mRNA encoding lysosome-targeted HIV antigen can expand a broad, polyclonal repertoire of antiviral T cells, offering a promising approach to HIV immunotherapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16249391      PMCID: PMC1895708          DOI: 10.1182/blood-2005-04-1513

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  34 in total

1.  Major histocompatibility complex class II-restricted presentation of a cytosolic antigen by autophagy.

Authors:  Falk Nimmerjahn; Slavoljub Milosevic; Uta Behrends; Elizabeth M Jaffee; Drew M Pardoll; Georg W Bornkamm; Josef Mautner
Journal:  Eur J Immunol       Date:  2003-05       Impact factor: 5.532

2.  Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection.

Authors:  Marcus Altfeld; Marylyn M Addo; Eric S Rosenberg; Frederick M Hecht; Paul K Lee; Martin Vogel; Xu G Yu; Rika Draenert; Mary N Johnston; Daryld Strick; Todd M Allen; Margaret E Feeney; James O Kahn; Rafick P Sekaly; Jay A Levy; Jürgen K Rockstroh; Philip J Goulder; Bruce D Walker
Journal:  AIDS       Date:  2003-12-05       Impact factor: 4.177

3.  HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors.

Authors:  Stephen A Migueles; Alisha C Laborico; W Lesley Shupert; M Shirin Sabbaghian; Ronald Rabin; Claire W Hallahan; Debbie Van Baarle; Stefan Kostense; Frank Miedema; Mary McLaughlin; Linda Ehler; Julia Metcalf; Shuying Liu; Mark Connors
Journal:  Nat Immunol       Date:  2002-10-07       Impact factor: 25.606

4.  A clinical grade cocktail of cytokines and PGE2 results in uniform maturation of human monocyte-derived dendritic cells: implications for immunotherapy.

Authors:  Andrew W Lee; Tuan Truong; Kara Bickham; Jean-Francois Fonteneau; Marie Larsson; Ida Da Silva; Selin Somersan; Elaine K Thomas; Nina Bhardwaj
Journal:  Vaccine       Date:  2002-12-19       Impact factor: 3.641

5.  HLA-B63 presents HLA-B57/B58-restricted cytotoxic T-lymphocyte epitopes and is associated with low human immunodeficiency virus load.

Authors:  Nicole Frahm; Sharon Adams; Photini Kiepiela; Caitlyn H Linde; Hannah S Hewitt; Mathias Lichterfeld; Kaori Sango; Nancy V Brown; Eunice Pae; Alysse G Wurcel; Marcus Altfeld; Margaret E Feeney; Todd M Allen; Timothy Roach; M Anne St John; Eric S Daar; Eric Rosenberg; Bette Korber; Francesco Marincola; Bruce D Walker; Philip J R Goulder; Christian Brander
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

6.  Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation.

Authors:  Karina Yusim; Can Kesmir; Brian Gaschen; Marylyn M Addo; Marcus Altfeld; Søren Brunak; Alexandre Chigaev; Vincent Detours; Bette T Korber
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

7.  Immunological and clinical responses in metastatic renal cancer patients vaccinated with tumor RNA-transfected dendritic cells.

Authors:  Zhen Su; Jens Dannull; Axel Heiser; Donna Yancey; Scott Pruitt; John Madden; Doris Coleman; Donna Niedzwiecki; Eli Gilboa; Johannes Vieweg
Journal:  Cancer Res       Date:  2003-05-01       Impact factor: 12.701

8.  Therapeutic dendritic-cell vaccine for simian AIDS.

Authors:  Wei Lu; Xiaoxian Wu; Yaozeng Lu; Weizhong Guo; Jean-Marie Andrieu
Journal:  Nat Med       Date:  2002-12-23       Impact factor: 53.440

9.  Advantage of rare HLA supertype in HIV disease progression.

Authors:  Elizabeth Trachtenberg; Bette Korber; Cristina Sollars; Thomas B Kepler; Peter T Hraber; Elizabeth Hayes; Robert Funkhouser; Michael Fugate; James Theiler; Yen S Hsu; Kevin Kunstman; Samuel Wu; John Phair; Henry Erlich; Steven Wolinsky
Journal:  Nat Med       Date:  2003-07       Impact factor: 53.440

10.  HIV-1 p55Gag encoded in the lysosome-associated membrane protein-1 as a DNA plasmid vaccine chimera is highly expressed, traffics to the major histocompatibility class II compartment, and elicits enhanced immune responses.

Authors:  Ernesto T A Marques; Priya Chikhlikar; Luciana Barros de Arruda; Ihid C Leao; Yang Lu; Justin Wong; Juei-Suei Chen; Barry Byrne; J Thomas August
Journal:  J Biol Chem       Date:  2003-06-24       Impact factor: 5.157

View more
  26 in total

1.  Extensive HLA class I allele promiscuity among viral CTL epitopes.

Authors:  Nicole Frahm; Karina Yusim; Todd J Suscovich; Sharon Adams; John Sidney; Peter Hraber; Hannah S Hewitt; Caitlyn H Linde; Daniel G Kavanagh; Tonia Woodberry; Leah M Henry; Kellie Faircloth; Jennifer Listgarten; Carl Kadie; Nebojsa Jojic; Kaori Sango; Nancy V Brown; Eunice Pae; M Tauheed Zaman; Florian Bihl; Ashok Khatri; Mina John; Simon Mallal; Francesco M Marincola; Bruce D Walker; Alessandro Sette; David Heckerman; Bette T Korber; Christian Brander
Journal:  Eur J Immunol       Date:  2007-09       Impact factor: 5.532

2.  Weighted lambda superstrings applied to vaccine design.

Authors:  Luis Martínez; Martin Milanič; Iker Malaina; Carmen Álvarez; Martín-Blas Pérez; Ildefonso M de la Fuente
Journal:  PLoS One       Date:  2019-02-08       Impact factor: 3.240

3.  Soluble HLA-G inhibits myeloid dendritic cell function in HIV-1 infection by interacting with leukocyte immunoglobulin-like receptor B2.

Authors:  Jinghe Huang; Patrick Burke; Yue Yang; Katherine Seiss; Jill Beamon; Thai Cung; Ildiko Toth; Florencia Pereyra; Mathias Lichterfeld; Xu G Yu
Journal:  J Virol       Date:  2010-08-11       Impact factor: 5.103

4.  Polyelectrolyte capsules-containing HIV-1 p24 and poly I:C modulate dendritic cells to stimulate HIV-1-specific immune responses.

Authors:  Winni De Haes; Stefaan De Koker; Charlotte Pollard; Derek Atkinson; Erika Vlieghe; Jessy Hoste; Joanna Rejman; Stefaan De Smedt; Johan Grooten; Guido Vanham; Ellen Van Gulck
Journal:  Mol Ther       Date:  2010-05-11       Impact factor: 11.454

Review 5.  Understanding and exploiting dendritic cells in human immunodeficiency virus infection using the nonhuman primate model.

Authors:  Simon M Barratt-Boyes; Kevin N Brown; Nada Melhem; Adam C Soloff; Sherrianne M Gleason
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

6.  High-level antigen expression and sustained antigen presentation in dendritic cells nucleofected with wild-type viral mRNA but not DNA.

Authors:  Nada M Melhem; Sherrianne M Gleason; Xiang Dong Liu; Simon M Barratt-Boyes
Journal:  Clin Vaccine Immunol       Date:  2008-07-30

Review 7.  Dendritic cell-based human immunodeficiency virus vaccine.

Authors:  C R Rinaldo
Journal:  J Intern Med       Date:  2009-01       Impact factor: 8.989

8.  Efficient in vitro expansion of human immunodeficiency virus (HIV)-specific T-cell responses by gag mRNA-electroporated dendritic cells from treated and untreated HIV type 1-infected individuals.

Authors:  Ellen R Van Gulck; Guido Vanham; Leo Heyndrickx; Sandra Coppens; Katleen Vereecken; Derek Atkinson; Eric Florence; Ilse Kint; Zwi Nisan Berneman; Viggo Van Tendeloo
Journal:  J Virol       Date:  2008-01-30       Impact factor: 5.103

9.  Selective inhibition of aldo-keto reductase 1C3: a novel mechanism involved in midostaurin and daunorubicin synergism.

Authors:  Anselm Morell; Eva Novotná; Jaroslav Milan; Petra Danielisová; Neslihan Büküm; Vladimír Wsól
Journal:  Arch Toxicol       Date:  2020-10-06       Impact factor: 5.153

10.  HLA-B*35-Px-mediated acceleration of HIV-1 infection by increased inhibitory immunoregulatory impulses.

Authors:  Jinghe Huang; James J Goedert; Eric J Sundberg; Thai Duong Hong Cung; Patrick S Burke; Maureen P Martin; Liliana Preiss; Jeffrey Lifson; Mathias Lichterfeld; Mary Carrington; Xu G Yu
Journal:  J Exp Med       Date:  2009-12-14       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.